CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 161 filers reported holding CLOVIS ONCOLOGY INC in Q1 2020. The put-call ratio across all filers is 0.64 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $33,896,000 | +62670.4% | 7,600 | -32.4% | 0.00% | -57.1% |
| Q4 2020 | $54,000 | -22.9% | 11,250 | -10.4% | 0.01% | -22.2% |
| Q3 2020 | $70,000 | -17.6% | 12,550 | 0.0% | 0.01% | -35.7% |
| Q2 2020 | $85,000 | +10.4% | 12,550 | +3.7% | 0.01% | -12.5% |
| Q1 2020 | $77,000 | -38.4% | 12,100 | -1.6% | 0.02% | -27.3% |
| Q4 2019 | $125,000 | – | 12,300 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |